Tempus AI Inc. stocks have been trading up by 6.55 percent after bullish coverage on its AI-driven healthcare data platform.

Tempus AI, Inc. (NASDAQ: TEM) today announced an extension of its data license agreement with Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX). Additionally, the two companies have entered into a new ...

This is the fifth installment of the mathematics series. In the first article, “Fermat Test — Another Principle of Primality ...

Researchers have replaced trial-and-error tuning of a recursive least squares identifier with a hill-climbing algorithm and a ...

Researchers from the National University of Singapore, A*STAR, and the Australian National University have demonstrated a ...

The Glamsterdam network upgrade will activate on Hoodi at epoch 132,352, slot 4,235,264 (October 26, 2026, 17:42:48 UTC). At ...

According to Ethereum researcher Toni Wahrstätter, Hoodi is the final testnet before Glamsterdam reaches mainnet. This ...

The DNA inside our cells isn’t just a series of instructions, but something far more dynamic. Like scientists, AI models ...

Two researchers building a startup around recursive self-improvement argue the term has been diluted to near-meaninglessness. Dhaval Adjodah, ...